StephenDProctorMD

PubMed

• 27 citations
  Severe renal toxicity due to intermediate-dose methotrexate.
  Allistair N. Stark, Graham Jackson, Peter Carey, Shahabul Arfeen, Stephen J. Proctor> ;Cancer Chemotherapy and Pharmacology. 1989 Jan 1
• What determines quality in maternity care? Comparing the perceptions of childbearing women and midwives.
  Proctor, S.> ;Birth. 1998 Jun
• Autoimmune haemolytic anaemia occurring in a patient with mycosis fungoides.
  White, S. I., Marsden, J. R., Marks, J. M., Proctor, S.> ;Br J Dermatol. 1984 Apr
• Progress in acute leukaemia in adults.
  Proctor, S. J., Hamilton, P. J., Reid, M. M., Hall, A. G., Carey, P.> ;Lancet. 1986 Jun 21
• Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.
  Taylor, W. B., Proctor, S. J., Bateman, D. N.> ;Br J Clin Pharmacol. 1984 Nov
• Failure of FAB classification to predict relapse-free survival in acute leukemia.
  Reid, M. M., Proctor, S. J.> ;Lancet. 1982 Jul 17
• Relationship of lymphocyte anisocytosis in chronic lymphatic leukaemia to mouse red cell rosetting capacity and clinical stage.
  Wastell, H. J., Proctor, S. J.> ;Acta Haematol. 1983
• Abnormal T lymphoproliferative disorder demonstrating in vitro suppressor and helper characteristics associated with Crohn''s disease.
  Proctor, S. J.> ;Br J Haematol. 1985 Apr
• Melphalan resistance in myeloma.
  Hall, A., Proctor, S. J., Harris, A. L.> ;Br J Haematol. 1986 May 01
• Hereditary haemorrhagic telangiectasia: a clinical analysis.
  Porteous, M. E., Burn, J., Proctor, S. J.> ;J Med Genet. 1992 Aug
• Deoxycoformycin in the treatment of leukemias and lymphomas.
  Smyth, J. F., Prentice, H. G., Proctor, S., Hoffbrand, A. V.> ;Ann N Y Acad Sci. 1985 Jan 01
• Mechanisms of drug resistance in acute leukaemia.
  Hall, A., Cattan, A. R., Proctor, S. J.> ;Leuk Res. 1989
• Altered immunology in haemophilia.
  Jones, P., Proctor, S., Dickinson, A., George, S.> ;Lancet. 1983 Jan 15
• Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity.
  Robson, C. N., Lewis, A. D., Wolf, C. R., Hayes, J. D., Hall, A., Proctor, S. J., Harris, A. L., Hickson, I. D.> ;Cancer Res. 1987 Nov 15
• Short course intermediate dose intravenous melphalan therapy in myeloma--relation to early emergence of drug resistance (phase II study).
  Sviland, L., Leggat, H., Harris, A. L., Bird, G., Proctor, S. J.> ;Acta Haematol. 1987
• Is it possible to catch leukaemia from a cat?
  Donaldson, L. J., Rankin, J., Proctor, S.> ;Lancet. 1994 Oct 8
• Subpopulations of thyroid autoantibody secreting lymphocytes in Graves'' and Hashimoto thyroid glands.
  McLachlan, S. M., Pegg, C. A., Atherton, M. C., Middleton, S. L., Dickinson, A., Clark, F., Proctor, S. J., Proud, G., Rees Smith, B.> ;Clin Exp Immunol. 1986 Aug 01
• Thyroid autoantibody synthesis by lymphocytes from different lymphoid organs: fractionation of B cells on density gradients.
  Atherton, M. C., McLachlan, S. M., Pegg, C. A., Dickinson, A., Baylis, P., Young, E. T., Proctor, S. J., Rees Smith, B.> ;Immunology. 1985 Jun 01
• Depression as component of post-cranial irradiation somnolence syndrome.
  Proctor, S. J., Kernaham, J., Taylor, P.> ;Lancet. 1981 May 30
• Mitochondrial DNA mutations in the haematopoietic system.
  Taylor, R. W., He, L., Proctor, S. J., Middleton, P. G., Turnbull, D. M.> ;Leukemia. 2004 Jan
• Umbilical cord blood banks in the UK.
  Proctor, S. J., Dickinson, A. M., Parekh, T., Chapman, C.> ;BMJ. 2001 Jul 14
• Lymphomatoid papulosis: response to treatment with recombinant interferon alfa-2b.
  Proctor, S. J., Jackson, G. H., Lennard, A. L., Marks, J.> ;J Clin Oncol. 1992 Jan
• Basophilia, t(15;17) translocation and atypical AML.
  Ademokun, A. J., Irving, J. A., Maung, Z. T., Howard, M. R., Proctor, S. J., Jackson, G. H.> ;Leukemia. 1995 Jan
• Why clinical research needs medical audit.
  Proctor, S. J.> ;Qual Health Care. 1993 Mar
• Position paper. Case for a strategic change in approach for clinical cancer trials and studies: a question of PACE (population adjusted clinical epidemiology)
  Proctor, S. J.> ;Med Pediatr Oncol. 1998 Dec
• Join now to see all